Ultra Market Research | Global Biopharmaceutical Third-Party Logistics Market
Global Biopharmaceutical Third-Party Logistics Market
Report ID : 594
Category : Pharmaceuticals
No Of Pages : 140
Published on: July 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Biopharmaceutical Third-Party Logistics Market
In 2023, the global biopharmaceutical third-party logistics (3PL) market was valued at US$ XX billion and is projected to reach around US$ XX billion by 2033, growing at a CAGR of XX% from 2024 to 2033. Biopharmaceutical 3PLs are crucial for delivering comprehensive logistical services to biopharmaceutical companies, including warehousing, distribution, customer, and financial services. They optimize supply chain operations by navigating regulatory complexities and ensuring product integrity. The increasing demand for capable 3PL providers reflects the biopharmaceutical industry's need for adept logistical support, which enhances operational efficiency and cost optimization.
Market Overview
The rapid expansion of the biopharmaceutical 3PL market is driven by its essential role in the pharmaceutical supply chain, ensuring seamless operations in a highly regulated industry. These providers must adhere strictly to government regulations, providing confidence in compliance for pharmaceutical manufacturers. Positioned at the crossroads of drug makers, wholesale distributors, healthcare providers, and patients, pharmaceutical logistics is vital for the safe and efficient delivery of medicines globally. The reliability of these logistics services is critical, as any disruption can impact treatment plans and patient safety.
Regional Stance
North America leads the biopharmaceutical industry, with the United States at the forefront of innovation and research. The U.S. boasts a robust ecosystem supporting advanced R&D and a diverse supply chain for biopharmaceutical development, production, and distribution. This innovation-driven industry is a significant contributor to national employment and economic growth. The U.S. is particularly noted for its vibrant start-up ecosystem and culture of collaboration, further establishing its dominance in biopharmaceutical advancement.
In contrast, Asia Pacific is the fastest-growing market in the biopharmaceutical sector, supported by robust government initiatives, regulatory reforms, and increased international collaboration. This region benefits from significant venture capital investments and a strong inclination towards adopting technological advancements, positioning it as a key player in the future landscape of biopharmaceuticals.
Report Highlights
By Product:
The warehousing and storage segment dominates the global biopharmaceutical 3PL market, highlighting the critical role of 3PL warehouses in providing comprehensive e-commerce fulfillment services. These warehouses, strategically located, are vital for efficient order fulfillment within the biopharmaceutical supply chain.
By Supply Chain:
Non-cold chain logistics currently dominate the market, reflecting the complexities and high costs associated with managing in-house distribution networks. Outsourcing these logistics functions to 3PL providers allows organizations to focus on their core competencies while benefiting from specialized warehousing expertise. The cold chain segment, essential for maintaining the quality and safety of temperature-sensitive pharmaceuticals, presents a significant growth opportunity due to its specialized requirements.
Market Dynamics
Driver:
The Role of Pharmaceutical 3PL Providers in Supply Chain Excellence
Pharmaceutical 3PL providers are integral to optimizing supply chain operations, managing critical tasks such as warehousing, order processing, distribution, and logistics management. These providers streamline the movement of products from manufacturing sites to distribution centers and beyond, ensuring timely delivery to healthcare facilities and enhancing patient access to essential medications.
Restraints:
Challenges in Biopharmaceutical Third-Party Logistics
Despite the benefits, outsourcing logistics to 3PL providers can introduce hidden costs, such as additional fees and surcharges, which may arise if service agreements are not carefully negotiated and monitored. Moreover, dependency on 3PL providers can pose risks, particularly if these providers face financial or operational challenges.
Opportunities:
The Evolution of Biopharmaceutical Third-Party Logistics
3PL providers are evolving into key players in the healthcare supply chain, offering services beyond traditional transportation and storage, such as procurement assistance to smaller retailers. This evolution provides a growth opportunity in decentralized supply chains characterized by high outsourcing costs and price sensitivity.
Recent Developments
In April 2022, Scilex Holding Company, a subsidiary of Sorrento Therapeutics, Inc., expanded its direct distribution network to include national and regional wholesalers and pharmacies.
In May 2024, Salesforce launched Unified Knowledge, enabling service organizations to use third-party data to enhance generative AI and self-service experiences.
Key Players in the Biopharmaceutical Third Party Logistics Market Agility Logistics AmerisourceBergen Corporation DB Schenker DHL International GmbH FedEx Corporation Kerry Logistics Network Limited Kuehne + Nagel International AG McKesson Corporation SF Express Co. Ltd. United Parcel Service of America, Inc.
Market Segmentation
By Service Type Warehousing & Storage Transportation Sea Freight Overland Air Freight Others
By Supply Chain Cold Chain Non-Cold Chain
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe
Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
Table of content 1. Introduction 1.1. Report Description 1.2. Research Methodology 1.2.1. Data Mining 1.2.2. Market Modeling and Forecasting 1.2.3. Data Validation 1.2.4. Industry Analysis
4. Biopharmaceutical Third-Party Logistics Market by Service Type 4.1. Introduction 4.2. Biopharmaceutical Third-Party Logistics Market Size and Growth Rate by Service Type (2021-2030) 4.3. Warehousing & Storage 4.3.1. Warehousing & Storage Market Size and Growth Rate (2022 - 2030) 4.4. Transportation 4.4.1. Transportation Market Size and Growth Rate (2022 - 2030) 4.5. Sea Freight 4.5.1. Sea Freight Market Size and Growth Rate (2021-2030) 4.6. Overland 4.6.1. Overland Market Size and Growth Rate (2021-2030) 4.7. Air Freight 4.7.1. Air Freight Market Size and Growth Rate (2021-2030) 4.8. Others 4.8.1. Others Market Size and Growth Rate (2021-2030)
5. Biopharmaceutical Third-Party Logistics Market by Supply Chain 5.1. Introduction 5.2. Biopharmaceutical Third-Party Logistics Market Size and Growth Rate by Supply Chain (2021-2030) 5.3. Cold Chain 5.3.1. Cold Chain Market Size and Growth Rate (2021-2030) 5.4. Non-Cold Chain 5.4.1. Non-Cold Chain Market Size and Growth Rate (2021-2030)
10. Company Profiles 10.1. Agility Logistics 10.1.1. Business Overview 10.1.2. Service Portfolio 10.1.3. Strategic Developments 10.1.4. Financial Overview
10.2. AmerisourceBergen Corporation 10.2.1. Business Overview 10.2.2. Service Portfolio 10.2.3. Strategic Developments 10.2.4. Financial Overview
10.3. DB Schenker 10.3.1. Business Overview 10.3.2. Service Portfolio 10.3.3. Strategic Developments 10.3.4. Financial Overview
10.4. DHL International GmbH 10.4.1. Business Overview 10.4.2. Service Portfolio 10.4.3. Strategic Developments 10.4.4. Financial Overview
10.5. FedEx Corporation 10.5.1. Business Overview 10.5.2. Service Portfolio 10.5.3. Strategic Developments 10.5.4. Financial Overview
10.6. Kerry Logistics Network Limited 10.6.1. Business Overview 10.6.2. Service Portfolio 10.6.3. Strategic Developments 10.6.4. Financial Overview
10.7. Kuehne + Nagel International AG 10.7.1. Business Overview 10.7.2. Service Portfolio 10.7.3. Strategic Developments 10.7.4. Financial Overview
10.8. McKesson Corporation 10.8.1. Business Overview 10.8.2. Service Portfolio 10.8.3. Strategic Developments 10.8.4. Financial Overview
10.9. SF Express Co. Ltd. 10.9.1. Business Overview 10.9.2. Service Portfolio 10.9.3. Strategic Developments 10.9.4. Financial Overview
10.10. United Parcel Service of America, Inc 10.10.1. Business Overview 10.10.2. Service Portfolio 10.10.3. Strategic Developments 10.10.4. Financial Overview
11. List of Tables and Figures Table Biopharmaceutical Third-Party Logistics Market Size and Market Share by Service Type (2021-2023) Table Biopharmaceutical Third-Party Logistics Market Size and Market Share by Service Type (2023-2030) Figure Warehousing & Storage Market Size and Growth Rate (2021-2030) Figure Transportation Market Size and Growth Rate (2021-2030) Figure Sea Freight Market Size and Growth Rate (2021-2030) Figure Overland Market Size and Growth Rate (2021-2030) Figure Air Freight Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Biopharmaceutical Third-Party Logistics Market Size and Market Share by Supply Chain (2021-2023) Table Biopharmaceutical Third-Party Logistics Market Size and Market Share by Supply Chain (2023-2030) Figure Cold Chain Market Size and Growth Rate (2021-2030) Figure Non-Cold Chain Market Size and Growth Rate (2021-2030) Table Biopharmaceutical Third-Party Logistics Market by Regions (2021-2023) Table Biopharmaceutical Third-Party Logistics Market by Regions (2023-2030) Figure North America Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table North America Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table North America Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table North America Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table North America Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Table North America Biopharmaceutical Third-Party Logistics by Country (2021-2023) Table North America Biopharmaceutical Third-Party Logistics by Country (2023-2030) Figure United States Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table United States Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table United States Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table United States Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table United States Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Canada Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Canada Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Canada Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Canada Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Canada Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Europe Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Europe Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Europe Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Europe Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Europe Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Table Europe Biopharmaceutical Third-Party Logistics by Country (2021-2023) Table Europe Biopharmaceutical Third-Party Logistics by Country (2023-2030) Figure Germany Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Germany Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Germany Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Germany Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Germany Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure France Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table France Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table France Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table France Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table France Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure UK Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table UK Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table UK Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table UK Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table UK Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Russia Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Russia Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Russia Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Russia Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Russia Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Italy Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Italy Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Italy Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Italy Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Italy Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Rest of Europe Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Rest of Europe Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Rest of Europe Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Rest of Europe Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Rest of Europe Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Asia-Pacific Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Asia-Pacific Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Asia-Pacific Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Asia-Pacific Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Asia-Pacific Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Table Asia-Pacific Biopharmaceutical Third-Party Logistics by Country (2021-2023) Table Asia-Pacific Biopharmaceutical Third-Party Logistics by Country (2023-2030) Figure China Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table China Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table China Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table China Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table China Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Japan Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Japan Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Japan Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Japan Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Japan Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure India Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table India Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table India Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table India Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table India Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Southeast Asia Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Southeast Asia Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Southeast Asia Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Southeast Asia Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Southeast Asia Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Rest of Asia-Pacific Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Rest of Asia-Pacific Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Rest of Asia-Pacific Biopharmaceutical Third-Party Logistics Market by ServiceType (2023-2030) Table Rest of Asia-Pacific Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Rest of Asia-Pacific Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure South America Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table South America Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table South America Biopharmaceutical Third-Party Logistics Market by ServiceType (2023-2030) Table South America Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table South America Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Table South America Biopharmaceutical Third-Party Logistics by Country (2021-2023) Table South America Biopharmaceutical Third-Party Logistics by Country (2023-2030) Figure Brazil Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Brazil Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Brazil Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Brazil Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Brazil Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Mexico Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Mexico Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Mexico Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Mexico Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Mexico Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Columbia Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Figure Rest of South America Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Rest of South America Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Rest of South America Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Rest of South America Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Rest of South America Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Middle East and Africa Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Middle East and Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Middle East and Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Middle East and Africa Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Middle East and Africa Biopharmaceutical Third-Party Logistics by Country (2021-2023) Table Middle East and Africa Biopharmaceutical Third-Party Logistics by Country (2023-2030) Figure Saudi Arabia Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Saudi Arabia Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Saudi Arabia Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Saudi Arabia Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Saudi Arabia Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure United Arab Emirates Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table United Arab Emirates Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table United Arab Emirates Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table United Arab Emirates Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table United Arab Emirates Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure South Africa Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table South Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table South Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table South Africa Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table South Africa Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030) Figure Rest of Middle East and Africa Biopharmaceutical Third-Party Logistics Market Size and Growth Rate (2021-2030) Table Rest of Middle East and Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2021-2023) Table Rest of Middle East and Africa Biopharmaceutical Third-Party Logistics Market by Service Type (2023-2030) Table Rest of Middle East and Africa Biopharmaceutical Third-Party Logistics by Supply Chain (2021-2023) Table Rest of Middle East and Africa Biopharmaceutical Third-Party Logistics by Supply Chain (2023-2030)
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Biopharmaceutical Third-Party Logistics and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Biopharmaceutical Third-Party Logistics Market for the past year and forecasts for the next six years.Global Biopharmaceutical Third-Party Logistics Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different biopharmaceutical third-party logistics categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biopharmaceutical Third-Party Logistics from different application industries in different regions.
By Service Type Warehousing & Storage Transportation Sea Freight Overland Air Freight Others
By Supply Chain Cold Chain Non-Cold Chain
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe
Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
